Mika Nishimura
Director/Board Member chez SI-BONE, INC.
Fortune : 702 218 $ au 31/03/2024
Profil
Mika Nishimura is the founder of BLG Group.
She currently holds four positions as an independent director at SI-BONE, Inc., HOYA Corp., Accuray, Inc., and MobileODT Ltd.
Previously, she held positions as Director-Global Marketing at Guidant Vascular Intervention, VP-International Sales, Operations & Marketing at ev3, Inc., Vice President-Commercialization at nVision Medical Corp., and Vice President-Commercial Development at Auxogyn, Inc. She received her undergraduate degree from Yale University and her MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACCURAY INCORPORATED
0,16% | 30/11/2023 | 156 056 ( 0,16% ) | 385 458 $ | 31/03/2024 |
SI-BONE, INC.
0,05% | 13/03/2024 | 19 350 ( 0,05% ) | 316 760 $ | 31/03/2024 |
Postes actifs de Mika Nishimura
| Sociétés | Poste | Début |
|---|---|---|
| SI-BONE, INC. | Director/Board Member | 04/03/2021 |
| ACCURAY INCORPORATED | Director/Board Member | 17/08/2021 |
| HOYA CORPORATION | Director/Board Member | 01/06/2022 |
| BLG Group | Founder | - |
MobileODT Ltd.
 MobileODT Ltd. Packaged SoftwareTechnology Services MobileODT Ltd. develops optical diagnostic devices and software services focused on early cancer detection. It uses mobile phones to detect cancer and also develops point-of-care diagnostic solutions for the global market. The firm’s product EVA System, functions on its own as an enhanced visual assessment screening or alongside any cervical cancer treatment. The company was founded by Ariel Beery and David Levitz in October 2012 and is headquartered in Tel Aviv, Israel. | Director/Board Member | - |
Anciens postes connus de Mika Nishimura
| Sociétés | Poste | Fin |
|---|---|---|
nVision Medical Corp.
 nVision Medical Corp. Hospital/Nursing ManagementHealth Services nVision Medical Corp. operates as a venture-backed medical device company. It develops a technology that can be used in the office of the gynecologist to diagnose the cause of infertility as well as ovarian cancer. The company was founded by Surbhi Sarna in January 2012 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2020 |
Auxogyn, Inc.
 Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01/01/2015 |
| Guidant Vascular Intervention | Sales & Marketing | - |
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Chief Operating Officer | - |
Formation de Mika Nishimura
| Yale University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SI-BONE, INC. | Health Technology |
| HOYA CORPORATION | Health Technology |
| ACCURAY INCORPORATED | Health Technology |
| Entreprise privées | 6 |
|---|---|
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
nVision Medical Corp.
nVision Medical Corp. Hospital/Nursing ManagementHealth Services nVision Medical Corp. operates as a venture-backed medical device company. It develops a technology that can be used in the office of the gynecologist to diagnose the cause of infertility as well as ovarian cancer. The company was founded by Surbhi Sarna in January 2012 and is headquartered in San Francisco, CA. | Health Services |
| Guidant Vascular Intervention | |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Health Technology |
| BLG Group | |
MobileODT Ltd.
MobileODT Ltd. Packaged SoftwareTechnology Services MobileODT Ltd. develops optical diagnostic devices and software services focused on early cancer detection. It uses mobile phones to detect cancer and also develops point-of-care diagnostic solutions for the global market. The firm’s product EVA System, functions on its own as an enhanced visual assessment screening or alongside any cervical cancer treatment. The company was founded by Ariel Beery and David Levitz in October 2012 and is headquartered in Tel Aviv, Israel. | Technology Services |
